When a child's birthday falls in autumn, a simple scheduling coincidence can mean the difference between catching influenza and staying healthy. That accidental insight has led Harvard Medical School researchers to prove what public health experts have long maintained: pediatric flu vaccines work, and they work powerfully for the youngest children.
The finding arrives at a critical moment. In January, the U.S. Centers for Disease Control and Prevention removed the annual influenza vaccine from its childhood schedule of recommended vaccines—a decision that prompted immediate backlash from medical societies and public health organizations and was ultimately blocked by the U.S. District Court in March. Now, a new study published in JAMA Pediatrics provides exactly the kind of evidence policymakers said they wanted to see.
The research hinges on a natural experiment baked into the American health system. Young children typically schedule their annual doctor visits around their birthdays. For children born in fall, that timing aligns perfectly with flu season preparations, making vaccination convenient. But summer-born children have appointments before the vaccine becomes available, requiring a second trip to the clinic—an extra burden that depresses vaccination rates. This random sorting by birth month created what researchers call "randomized data," where children are essentially assigned to vaccinated or unvaccinated groups by nothing more than the month they were born.
Christopher Worsham, first author of the study and assistant professor of medicine at Massachusetts General Hospital, and his colleagues analyzed insurance claims for children ages two to five across five flu seasons between 2016 and 2023, excluding the COVID-disrupted 2020–2021 and 2021–2022 seasons. The pattern was unmistakable: fall-born children had vaccination rates between 8.6 and 12.5 percentage points higher than summer-born peers, and their influenza diagnosis rates were 1.0 to 1.4 percentage points lower in each season.
The numbers translate to something profound: for every 100 vaccinated children, between nine and 14 fewer catch the flu. Scaled across the United States, that represents hundreds of thousands—possibly a million—preventable flu cases every year. Anupam Jena, senior author and Joseph P. Newhouse Professor of Health Care Policy at Harvard Medical School, called it "a huge effect size."
The study offers something rare in vaccine research: clean, randomized evidence drawn from real-world data rather than controlled trials. To verify that their finding reflected the vaccine's true effect and not some other seasonal factor, the researchers examined whether summer- and fall-born children showed differences in catching non-vaccine-preventable illnesses like the common cold or gastrointestinal viruses. They didn't—suggesting the vaccine, not some other variable, accounts for the difference in flu rates.
The strength of this protection does fade with age. After children turn five, birthdays no longer predict vaccination status as reliably, and the influenza diagnosis gap between summer- and fall-born children closes. But the researchers emphasize this doesn't mean the vaccine loses efficacy in older populations—only that this particular experimental method can no longer measure it.
As Worsham put it plainly: "It comes down to: vaccines work." At a time when childhood immunizations face renewed scrutiny, these findings offer solid ground for confidence in this particular shot.